findmyKOL
Clinical trialNCT05201404RecruitingPhase 3Interventional

Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

SponsorCan-Fite BioPharmaEnrollment471CirrhosisHepatocellular Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Bosnia and Herzegovina
  • 841 University Clinical Centre of Republic of Srpska

    Banja Luka, Bosnia and Herzegovina

    Not, yet, recruiting
  • 843 University Clinical Hospital Mostar

    Mostar, Bosnia and Herzegovina

    Not, yet, recruiting
  • 842 University Clinical Centre Sarajevo

    Sarajevo, Bosnia and Herzegovina

    Not, yet, recruiting
Bulgaria
  • 831 Dept of Medical Oncology, Complex Oncology Ctr - Burgas Eood

    Burgas, Bulgaria

    Not, yet, recruiting
  • 835 First Department of Medical Oncology, Gastroenterology and Pulmology, Complex Oncology Center - Plovdiv Eood, Plovdiv

    Plovdiv, Bulgaria

    Not, yet, recruiting
  • Medical Center Leo Clinic Eood Plovdiv

    Plovdiv, Bulgaria

    Not, yet, recruiting
  • 834 Medical Oncology Dept, Univ Multiprofile Hospital for Active Treatment "sv. Ivan Rilski" Ead, Sofia

    Sofia, Bulgaria

    Recruiting
Israel
  • 518 Rabin Medical Center Beilinson Hospital

    Petah Tikva, Israel

    Recruiting
Moldova
  • 872 Imsp Institute of Oncology

    Chisinau, Moldova

    Recruiting
Poland
  • Site 858

    Koszalin, Poland

    Not, yet, recruiting
  • Site 852

    Krakow, Poland

    Not, yet, recruiting
  • Site 857

    Mysłowice, Poland

    Not, yet, recruiting
  • Site 859

    Przemyśl, Poland

    Not, yet, recruiting
  • Site 855

    Warsaw, Poland

    Not, yet, recruiting
  • Site 850

    Wroclaw, Poland

    Not, yet, recruiting
Romania
  • 802 Institutul Regional de Gastroenterologie Si Hepatologie

    Cluj-Napoca, Romania

    Recruiting
  • 807 Iocn, Medical Oncology

    Cluj-Napoca, Romania

    Not, yet, recruiting
  • 809 Spitalul Clinic Judetean de Urgenta Constanta Oncology Dept

    Constanța, Romania

    Not, yet, recruiting
  • 801 Oncology Center "sf. Nectarie" Medical Oncology

    Craiova, Romania

    Recruiting
  • 803 Oncolab Srl

    Craiova, Romania

    Recruiting
  • 805 Euroclinic Lasi

    Iași, Romania

    Recruiting
  • 810 Iro Iasi-Clinica Oncologie Medicala

    Iași, Romania

    Recruiting
  • 808 Spitalul Clinic Pelican Oradea Oncology Department

    Oradea, Romania

    Recruiting
  • 804 Oncomed - Medical Oncology

    Timișoara, Romania

    Recruiting
  • 806 Oncocenter Oncologie Clinica Srl

    Timișoara, Romania

    Recruiting
Serbia
  • 821 Clinic for Gastroenterology and Hepatology, Military Medical Academy

    Belgrade, Serbia

    Not, yet, recruiting
  • 822 Oncology Institute of Vojvodina

    Kamenitz, Serbia

    Not, yet, recruiting
  • 823 Oncology Department, Health Center Kladovo

    Kladovo, Serbia

    Not, yet, recruiting
  • 824 Univ Clin Centre Kragujevac, Dept of Oncology

    Kragujevac, Serbia

    Not, yet, recruiting
Slovakia
  • Site 867

    Banská Bystrica, Slovakia

    Not, yet, recruiting
  • Site 865

    Košice, Slovakia

    Not, yet, recruiting
United States
  • Site 881

    Dallas, Texas, United States

    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Mar 2023
Primary completion
28 Feb 2026
Completion
31 Oct 2026
Last update posted
29 Apr 2025
Registered enrollment
471
Registry id
NCT05201404

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.